Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin: A Novel Weapon Against Inflammation
Bo Bai, Haibo Chen
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
Natalia Żeber‐Lubecka, Michał Ciebiera, Ewa E. Hennig
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14126-14126
Open Access | Times Cited: 44
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
Amanda Adler, Ruth L. Coleman, José Leal, et al.
The Lancet (2024) Vol. 404, Iss. 10448, pp. 145-155
Closed Access | Times Cited: 39
Examining the clinical relevance of metformin as an antioxidant intervention
Angelika Buczyńska, Iwona Sidorkiewicz, Adam Krętowski, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1834-1834
Open Access | Times Cited: 73
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
Clifford J. Bailey, Mike Gwilt
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 30
From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction
Tijana Srdić, Siniša Đurašević, Iva Lakić, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7770-7770
Open Access | Times Cited: 14
Coronary inflammation based on pericoronary adipose tissue attenuation in type 2 diabetic mellitus: effect of diabetes management
Yuankang Liu, Lisong Dai, Yue Dong, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial
Jelena Petković-Dabić, Ivana Binić, Bojana Carić, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 46-46
Open Access | Times Cited: 1
Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
Wiebe M. C. Top, Adriaan Kooy, Coen D.A. Stehouwer
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 312-312
Open Access | Times Cited: 32
Metformin Alters mRNA Expression of FOXP3, RORC, and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 281-281
Open Access | Times Cited: 7
Metformin Intervention—A Panacea for Cancer Treatment?
Angelika Buczyńska, Iwona Sidorkiewicz, Adam Krętowski, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1336-1336
Open Access | Times Cited: 27
Metformin: new applications for an old drug
Amirreza Naseri, Sarvin Sanaie, Sina Hamzehzadeh, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2022) Vol. 34, Iss. 2, pp. 151-160
Closed Access | Times Cited: 23
The relationship between adipokine levels and bone mass—A systematic review
Darren Mangion, Nikolai Paul Pace, Melissa M. Formosa
Endocrinology Diabetes & Metabolism (2023) Vol. 6, Iss. 3
Open Access | Times Cited: 15
Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators
Róisín Hambly, Niamh Kearney, Rosalind Hughes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6969-6969
Open Access | Times Cited: 15
Exploring the Long-Term Tissue Accumulation and Excretion of 3 nm Cerium Oxide Nanoparticles after Single Dose Administration
Lena M. Ernst, Laura Mondragón, Joana Ramis, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 765-765
Open Access | Times Cited: 13
Targeting the hallmarks of aging to improve influenza vaccine responses in older adults
Andreia N. Cadar, Dominique E. Martin, Jenna M. Bartley
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Dysregulation of the mRNA Expression of Human Renal Drug Transporters by Proinflammatory Cytokines in Primary Human Proximal Tubular Epithelial Cells
Yik Pui Tsang, Tianran Hao, Qingcheng Mao, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 285-285
Open Access | Times Cited: 5
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
Lidan Hu, Wenmin Wang, Xiangjun Chen, et al.
Brain‐X (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
ATP Alters the Oxylipin Profiles in Astrocytes: Modulation by High Glucose and Metformin
Alexey I. Drozhdev, Vladislav O. Gorbatenko, Sergey V. Goriainov, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 293-293
Open Access
Metformin accelerates zebrafish heart regeneration by inducing autophagy
Fangjing Xie, Shisan Xu, Yingying Lü, et al.
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 29
High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
Bo Bai, Min Cheng, Lingyan Jiang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 28
Metformin abrogates pathological TNF-α-producing B cells through mTOR-dependent metabolic reprogramming in polycystic ovary syndrome
Na Xiao, Jie Wang, Ting Wang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 20
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
Abira Usman, Kevin P. Bliden, Alastair Cho, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 53, Iss. 2, pp. 363-371
Open Access | Times Cited: 19
Ground and Excited State Dipole Moments of Metformin Hydrochloride using Solvatochromic Effects and Density Functional Theory
Semahegn Asemare, Abebe Belay, Alemu Kebede, et al.
Journal of Fluorescence (2023) Vol. 34, Iss. 3, pp. 1207-1217
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top